Prof.dr. A. de Boer

Update Persondata

• cardiovascular
• clinical
• daily
• diseases
• drugs
• effectiveness
• epidemiologist
• factors
• pharmacogenetics
• pharmacologist
• pharmacotherapy
• practice
• quality
• risk

Active as

Publications

(the most recent at the top)

Number of Patients Studied Prior to Approval of New Medicines: A Database Analysis

Interpretation and inference in noninferiority randomized controlled trials in drug research.

Clinical and economic consequences of pharmacogenetic-guided dosing of warfarin

Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa.

Pharmacogenetics: from bench to byte

All publications..

Enhanced publications

(the most recent at the top)

Doctoral Thesis: Mechanism-based drug exposure classification in pharmacoepidemiological studies

Doctoral Thesis: From new molecules to leads for innovation : studies on the post-innovation learning cycle for pharmaceuticals

Doctoral Thesis: Assessment of drug therapy in Parkinson’s disease

Current research

(the most recent research is at the top)
Project leader	Patient characteristics and risk of outcomes after total hip and knee joint arthroplasty
Project leader	Population-based studies of drug treatment

Completed research projects

(the most recent research is at the top)
Project leader	Innovation in the design of research on efficacy and safety of new drugs
Project leader	Improvement of access and reimbursement trajectories and beyond
Supervisor	Costs and effects of statin therapy in daily practice
Project leader	Effectiveness of cholesterol-lowering therapy and the role of the cholesteryl ester transfer protein gene in the general population

Classification

D23340	Biopharmacology, toxicology